Kenneth Barshop is a Gastroenterology physician. OpenAlex indexes 38 publications with 470 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
687 Main St
Branford, CT 064053612
Telephone
617-732-6660Provider last certified this registry record 19 Apr 2022.
Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202525 payments
- Takeda Pharmaceuticals U.S.A., Inc.Program year20254 payments
- Janssen Biotech, Inc.Program year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
82.8%Proton pump inhibitor57.8%Omeprazole68%Pantoprazole Sodium20%Esomeprazole Magnesium12%Part D≥107 patientsH2 blocker11.6%Famotidine100%Part D≥28 patients+ 5 more classes in this area
Cardiovascular
8.3%Bile Acid Sequestrant8.3%Cholestyramine74%Colestipol Hcl26%Part D<11 patientsSensory organs
4.6%Corticosteroid4.6%Hydrocortisone65%Procto-Med Hc35%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Twice-Daily Proton Pump Inhibitor Induces Higher Remission Rate in Eosinophilic Esophagitis Than Once-Daily Regimen Regardless of Total Daily Dose
The American Journal of Gastroenterology
2024 - Baseline Peripheral Eosinophil Count Independently Predicts Proton Pump Inhibitor Response in Eosinophilic Esophagitis
Journal of Clinical Gastroenterology
2023 - Rectal Evacuation Disorders are Associated With Poor Bowel Preparation in Patients With Chronic Constipation
Journal of Clinical Gastroenterology
2021 - CSP01, a Novel Superabsorbent Hydrogel, Reduces Colonic Transit Time in Patients With Chronic Idiopathic Constipation in a Randomized, Double-blind, Controlled Pilot Clinical Trial
Journal of Neurogastroenterology and Motility
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Josep M. Llovet
Institució Catalana de Recerca i Estudis Avançats
Joseph J.�Y. Sung
Nanyang Technological University
Neeraj Bhala
The Royal Melbourne Hospital
Jordi Bruix
Hospital Clínic de Barcelona
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”